Nrgene Technologies Ltd · TASE:NRGN
Nrgene Technologies — Investor Presentation (March 2023)
19 slides from Nrgene Technologies's investor presentation, March 2023
Slide 1: Capital Markets Presentation
Capital Markets Presentation MARCH 2023
Slide 2: Disclaimer
Disclaimer • The objective of this presentation is to present the activity of NRGene Technologies Ltd. (the “Company”) and to provide preliminary and basic information regarding its activities. In accessing this presentation, you agree to be bound by the following terms and conditions. • This presen
Slide 3: Agenda
Agenda • About NRGene • The Company’s Technology and Activities • Business Models • Innovative End-Products Development • IP Development Projects in Return for Royalties • Global Trends Impacting the Company’s Activities • Financial Results’ Highlights © 2 0 2 3 AL L R I G H T S R E S E R V E D 3
Slide 4: About NRGene
About NRGene NRGene Technologies Ltd. is an AgTech company engaged in research and development of IP- based technological products. The company develops varieties and traits of crops and animals, using its technology in the field of artificial intelligence (AI), to analyze genetic information based
Slide 5: NRGene's AI Technology was Validated by Leading Companies Worldwide
NRGene’s Artificial Intelligence (AI) Technology 2015 Launch of genomics was Validated by Leading Companies Worldwide analysis solutions (services) A proven technology that has been successfully implemented in over 300 projects across various industries 2017 Multi-year subscription agreements of the
Slide 6: NRGene's Technology
NRGene’s Technology TM BREEDING.AI The benefits AI Technologies Crops and Animals Breeding ✓ Reduces development time ✓ Reduces costs Multi-year Data: ✓ Increases likelihood • Field performance of success • Climate • Genomics data • Soil and Irrigation NEW ENRICHED VARIETY • Pests and diseases 1st 2
Slide 7: The Company's Activities
The Company’s Activities AI Technology A cloud-based analytical platform with proven results in hundreds of projects B R E E D I NG . AI TM across dozens of species (crops and animals). The system predicts improved genetic combinations and provides optimized and accurate natural AI Technology breedi
Slide 8: Business Models
Business Models Subscription agreements and IP development of genomics analysis services traits and varieties TM B R E E D I NG . AI • Strategic Collaborations Crops and Animals AI Technology Cocoa Coffee • Genotyping (DNA tests) Computational Tools For Crops and Revenues from royalties Genomics Ana
Slide 9: NRGene Engages in Partnerships to Develop Varieties and Commercialize End-Products
NRGene Engages in Partnerships to Develop Varieties and Commercialize End-Products Strategic collaborations ensure a complete presence in the agriculture value chain and maximizing value creation for the end-customer Strategic partner Varieties Seed Farmers Packaging Distribution End-customer develo
Slide 10: Innovative End-product Development in Emerging Markets
Innovative End-product Development in Emerging Markets Project | Partner … 2022 2023 2024 2025 2026 … 2030 IP development business model in return for end-product sales* Seedlings grown in vertical farming for dairy cattle feed | 2022: Development by NRGene 2024: revenues from end-product sales (JV)
Slide 11: Seedlings Grown in Vertical Farming for Dairy Cattle Feed
Seedlings Grown in Vertical Farming for Dairy Cattle Feed August 2022 Collaboration agreement with Granot Group Strategic collaboration with the Granot Group to develop and commercialize elite wheat varieties* November 2022 First milestone: identification Dairy cattle feed market** of wheat varietie
Slide 12: Black Soldier Fly (BSF) as an Alternative to Animal-Based Protein Source
Black Soldier Fly (BSF) as an Alternative to Animal-Based Protein Source 2022 Development of BSF’s genomics infrastructure Increasing the efficiency of the BSF for commercial scale manufacturing as a key driver of circular economy and sustainability January 2023 Joining the BSF consortium $3.4B of t
Slide 13: Cherry Tomato Varieties for the Frozen Food Market
Cherry Tomato Varieties for the Frozen Food Market February 2022 Project launch Naturally Dried, Stored Frozen, Consumed Fresh November 2022 Alpha hybrid varieties selection x4 Potential cumulative More vitamins (compared TAM (2030) revenue of the company (and/or partnership), until 2030 February 20
Slide 14: IP Development Projects in Return for Royalties
IP Development Projects in Return for Royalties The revenue potential in significant projects (to date): Potential annual Project Expected Expected year Expected royalties (throughout Commercialization status market size development period* of initial royalties the project's lifetime)*** (seeds/vari
Slide 15: IP Development Projects in Return for Royalties - Status
IP Development Projects in Return for Royalties - Status Project | Partner … 2022 2023 2024 2025 2026 … 2030 ToBRFV resistance in 2022: Commercialization 2020: Development by NRGene 2023: Royalties tomatoes | Philoseed and implementation High-quality cherry tomato varieties 2021: Development by NRGe
Slide 16: Genotyping (DNA Tests)
Genotyping (DNA Tests) Leveraging NRGene's technology to generate recurring revenue through long-term engagements with customers Overview of genotyping’s market penetration (starting in Q4, 2020) $3.2M 16% 80% Total booking* Increase in bookings (signed Customers growth agreements) since 2021 since
Slide 17: Food Security and Sustainability
Food Security and Sustainability Global Trends Impacting the Company’s Activities Global Climate Alternatives to meat food crisis change and healthy food NRGene's technology increases agricultural Increasing populations and Reduction in arable land and The negative impact of animal- productivity, wh
Slide 18: 2022 Financial Results Highlights (US Dollars in Thousands)
2022 Financial Results Highlights* (US Dollars in Thousands) Financial data 2022 2021 Comments End of subscription agreement with Bayer (December 2021), partially offset by increase in revenues from genomic services; Focusing on long- Revenues 3,159 4,463 term projects (DNA tests and strategic colla
Slide 19: Questions?
Questions? NRGene Ltd. @NRGene nrgene.com info@nrgene.com Thank you! 19
NRGene Technologies — Investor Presentation (March 2023) on 6ix